4.2 Article

Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age

期刊

SEMINARS IN FETAL & NEONATAL MEDICINE
卷 16, 期 2, 页码 88-93

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.siny.2010.10.003

关键词

Non-invasive prenatal diagnosis; Cell-free fetal nucleic acids; Fetal aneuploidy; Trisomy 21; Monogenic diseases; Next-generation sequencing

资金

  1. University Grants Committee of the Government of the Hong Kong Special Administrative Region, China [AoE/M-04/06]
  2. Hong Kong Research Grants Council [CUHK463109]
  3. Innovation and Technology Fund [ITS/054/09]
  4. Sequenom
  5. Li Ka Shing Foundation

向作者/读者索取更多资源

Prenatal diagnosis is an important part of obstetrics care. In the current prenatal programmes, definitive diagnosis of fetal genetic or chromosomal conditions is conducted through fetal sampling by amniocentesis or chorionic villus sampling. To obviate the risks of fetal miscarriage that are associated with the invasive sampling procedures, we have been developing non-invasive prenatal diagnostic tests based on cell-free fetal DNA analysis from maternal plasma. To date, fetal sex and rhesus D status determination by circulating fetal DNA analysis is performed clinically in many centres. Strategies for the non-invasive diagnosis of monogenic diseases have been developed. Accurate detection of fetal trisomy 21 by next-generation sequencing has been achieved. Many of the non-invasive prenatal tests could be introduced to the clinics as soon as cost-effective and high throughput protocols are developed. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据